#PrecisionDiagnostics

Genes & Diseases Journal

@genesndiseases.bsky.social

3 months ago

This latest study presents MD ELAAA, a dual-mode #Biosensing platform that integrates NP14 with plasmonic colorimetry & dynamic light scattering, underscoring its potential for early #PrecisionDiagnostics. @texasscience.bsky.social #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

星良孝 Yoshitaka Hoshi

@yoshitakahoshi.bsky.social

4 months ago

【Labcorp × Roche、デジタル病理診断で提携】

✔ 病理スライドをデジタル化し、AIによる腫瘍診断支援を実現
✔ がん病理解析を中心に、Labcorp全米ネットワークへ展開
✔ 病理医不足・地域格差に対応し、リモート診断を加速

#Labcorp #Roche #DigitalPathology #AI医療 #VENTANADP600 #病理診断 #臨床検査 #がん診断 #医療DX #RemoteDiagnostics #PrecisionDiagnostics

shubh

@shubham83.bsky.social

5 months ago

🏥 Liquid Biopsy Market expected to grow globally to USD 24.74 Million by 2034, CAGR 10.52%. lifestyle.mykmlk.com/story/521517... #MedTech #PrecisionDiagnostics

@healthdivine.bsky.social

7 months ago

📡 Advanced nuclear imaging! Germany’s #SPECT market leads with hybrid systems, AI & cardiac care focus.
#PrecisionDiagnostics #GermanyHealth #NuclearMedicine #Radiopharma

www.marketresearchfuture.com/reports/germ...

Attomarker

@attomarker.bsky.social

8 months ago

Professor Shaw highlights how the antibody spectrum test offers a vital way to understand the body's reaction to SARS-CoV-2. By looking closely at an individual's immune response to 14 different SARS-CoV-2 variants, we gain crucial insights. #COVID19Research #PrecisionDiagnostics

@healthdivine.bsky.social

9 months ago

Spain is betting big on biochips for precision medicine and diagnostics. 🔍🧬
#BiochipsSpain #PrecisionDiagnostics #GenomicsTech #MedTech

www.marketresearchfuture.com/reports/spai...

Attomarker

@attomarker.bsky.social

9 months ago

The complexities of Long COVID, as highlighted by recent trial outcomes and the varied immune profiles, underscore the need for deeper understanding. This includes specific populations and atypical responses. #LongCOVIDResearch #PrecisionDiagnostics

PANCAID

@pancaid.bsky.social

9 months ago

Poster of High Level Seminar on Precision Diagnostics for Precision Cancer Care. Subline: Improving Patient Access to Innovation Hosted by MEP Vasile (Vlad) Voiculescu European Parliament - Brussels Room SPAAK 7C50 May 20th, 2025 - 14:00 - 18:00 Organised by EU-funded project Instand-NGS4P

PANCAID Coordinator Prof. Klaus Pantel joins a high-level seminar on #PrecisionDiagnostics & NGS in cancer care, hosted by MEP Vlad Voiculescu, organised by #Instand-NGS4P

The message: We need to accelerate access to innovative diagnostics like #LiquidBiopsy for every patient in 🇪🇺.

Attomarker

@attomarker.bsky.social

10 months ago

Preparations are also being made to onboard a new clinic in Germany. This expansion aims to increase access to testing in Europe and contribute to our international data set.

#Germany #PrecisionDiagnostics #HealthInnovation

Attomarker

@attomarker.bsky.social

10 months ago

The Attomarker COVID Antibody Spectrum Test is imminently launching in the USA. Work is underway to establish its availability.

#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

11 months ago

Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK - PharmaTimes Collaboration expands AI-based risk profiling tools

#cancerdiagnostics #diagnostics #AIdiagnostics #personalisedcancerdiagnostics #precisiondiagnostics #Diagnexia #Stratipath #AIbreastcancerdiagnostics #breastcancerdiagnostics #AIbasedriskprofilingtools #StratipathBreast #precisecancerdiagnostics #precisiononcology
pharmatimes.com/news/diagnex...

HUMAN Doctoral Network

@human-dn.bsky.social

1 year ago

🌟 Don’t miss the first 2025 HUMAN Webinar! 🌟

📅 7 Feb 2025 | 13:00 CET
🎙️ Featuring: Purva Kulkarni, Head of Translational Metabolomics, Radboud UMC
💡Free for all and open to anyone interested!

🔗 Link: bit.ly/humandn_webinars

#PrecisionDiagnostics #Metabolomics #RareDiseases #HUMAN #Webinar